| Дата публикации | Название | Авторы |
| 2023 | Antiviral Potential of Antillogorgia americana and elisabethae Natural Products against nsp16–nsp10 Complex, nsp13, and nsp14 Proteins of SARS-CoV-2: An In Silico Investigation | Pokharkar, O.; Lakshmanan, H.; Zyryanov, G. V.; Tsurkan, M. V. |
| 2023 | ANTIVIRAL PROPERTIES OF VERDAZYLS AND LEUCOVERDAZYLS AND THEIR ACTIVITY AGAINST GROUP B ENTEROVIRUSES | Volobueva, A. S.; Zarubaev, V. V.; Fedorchenko, T. G.; Lipunova, G. N.; Tungusov, V. N.; Chupakhin, O. N. |
| 2022 | Computational Analysis of Molnupiravir | Sharov, A. V.; Burkhanova, T. M.; Tok, T. T.; Babashkina, M. G.; Safin, D. A. |
| 2015 | Experimental comparative pharmacokinetics of levofloxacin, triazavirine, and related conjugate | Blazhennikova, I. V.; Kurpyakova, A. F.; Bykov, V. N.; Geibo, D. S.; Nikiforov, A. S.; Stepanov, A. V.; Charushin, V. N.; Chupakhin, O. N.; Kotovskaya, S. K.; Rusinov, V. L. |
| 2004 | Fluorinated Derivatives of Benz[4,5]imidazo[1,2-b][1,3] thiazole - Inhibitors of Reproduction of Measles Virus | Pokrovskii, A. G.; Il'Icheva, T. N.; Kotovskaya, S. K.; Romanova, S. A.; Charushin, V. N.; Chupakhin, O. N. |
| 2023 | Natural Products from Red Algal Genus Laurencia as Potential Inhibitors of RdRp and nsp15 Enzymes of SARS-CoV-2: An In Silico Perspective | Pokharkar, O.; Anumolu, H.; Zyryanov, G. V.; Tsurkan, M. V. |
| 2012 | A new antiviral drug triazavirin: results of phase II clinical trial | Kiselev, O. I.; Deyeva, E. G.; Melnicova, T. I.; Kozeletskaia, K. N.; Klselev, A. S.; Rusinov, V. L.; Charushin, V. N.; Chupahin, O. N. |
| 2023 | Novel Substituted Azoloazines with Anticoagulant Activity | Spasov, A. A.; Fedorova, O. V.; Rasputin, N. A.; Ovchinnikova, I. G.; Ishmetova, R. I.; Ignatenko, N. K.; Gorbunov, E. B.; Sadykhov, G. A. O.; Kucheryavenko, A. F.; Gaidukova, K. A.; Sirotenko, V. S.; Rusinov, G. L.; Verbitskiy, E. V.; Charushin, V. N. |
| 2023 | Plant Coumarins with Anti-HIV Activity: Isolation and Mechanisms of Action | Sharapov, A. D.; Fatykhov, R. F.; Khalymbadzha, I. A.; Zyryanov, G. V.; Chupakhin, O. N.; Tsurkan, M. V. |
| 2021 | Redox Conversions of 5-Methyl-6-nitro-7-oxo-4,7-dihydro-1,2,4triazolo[1,5-a]pyrimidinide l-Arginine Monohydrate as a Promising Antiviral Drug | Ivoilova, A.; Mikhalchenko, L. V.; Tsmokalyuk, A.; Leonova, M.; Lalov, A.; Mozharovskaia, P.; Kozitsina, A. N.; Ivanova, A. V.; Rusinov, V. L. |
| 2023 | The safety and efficacy of oral antiviral drug VV116 for treatment of COVID-19: A systematic review | Xiao, N.; Huang, X.; Kang, X.; Zang, W.; Li, B.; Kiselev, S. |
| 2023 | Structural and Synthetic Aspects of Small Ring Oxa- and Aza-Heterocyclic Ring Systems as Antiviral Activities | Manna, S.; Das, K.; Santra, S.; Nosova, E. V.; Zyryanov, G. V.; Halder, S. |
| 2022 | Synthesis of Pyrimidine Conjugates with 4-(6-Amino-hexanoyl)-7,8-difluoro-3,4-dihydro-3-methyl-2H-[1,4] benzoxazine and Evaluation of Their Antiviral Activity | Krasnov, V. P.; Musiyak, V. V.; Levit, G. L.; Gruzdev, D. A.; Andronova, V. L.; Galegov, G. A.; Orshanskaya, I. R.; Sinegubova, E. O.; Zarubaev, V. V.; Charushin, V. N. |
| 2012 | Toxicity of Triazavirin, a Novel Russian Antiinfluenza chemotherapeutic | Loginova, S. Ya.; Borisevich, S. V.; Rusinov, V. L.; Ulomsky, U. N.; Charushin, V. N.; Chupakhin, O. N. |
| 2022 | Triazavirin—A Novel Effective Antiviral Drug | Chupakhin, O. N.; Rusinov, V. L.; Varaksin, M. V.; Ulomskiy, E. N.; Savateev, K. V.; Butorin, I. I.; Du, W.; Sun, Z.; Charushin, V. N. |
| 2022 | An Update of Lectins from Marine Organisms: Characterization, Extraction Methodology, and Potential Biofunctional Applications | Ahmmed, M. K.; Bhowmik, S.; Giteru, S. G.; Zilani, M. N. H.; Adadi, P.; Islam, S. S.; Kanwugu, O. N.; Haq, M.; Ahmmed, F.; Ng, C. C. W.; Chan, Y. S.; Asadujjaman, M.; Chan, G. H. H.; Naude, R.; Bekhit, A. E. -D. A.; Ng, T. B.; Wong, J. H. |
